These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35222998)

  • 21. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli.
    Haruki Y; Hagiya H; Haruki M; Sugiyama T
    J Infect Chemother; 2018 Nov; 24(11):944-947. PubMed ID: 29803763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
    Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
    Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
    Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
    Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
    Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.
    Tamma PD; Conley AT; Cosgrove SE; Harris AD; Lautenbach E; Amoah J; Avdic E; Tolomeo P; Wise J; Subudhi S; Han JH;
    JAMA Intern Med; 2019 Mar; 179(3):316-323. PubMed ID: 30667477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens.
    Luzzaro F; Pagani L; Porta F; Romero E
    J Chemother; 1995 Jun; 7(3):175-8. PubMed ID: 7562009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance phenotypes and susceptibility of contemporary Serratia isolates in the university hospital of Crete, Greece.
    Samonis G; Vardakas KZ; Maraki S; Stamouli P; Mavromanolaki VE; Kofteridis DP; Falagas ME
    Infect Dis (Lond); 2017; 49(11-12):847-853. PubMed ID: 28768448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
    Yang CC; Li SH; Chuang FR; Chen CH; Lee CH; Chen JB; Wu CH; Lee CT
    BMC Infect Dis; 2012 Sep; 12():206. PubMed ID: 22947300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and microbiological survey of Serratia marcescens infection during HIV disease.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    Eur J Clin Microbiol Infect Dis; 2000 Apr; 19(4):248-53. PubMed ID: 10834812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Occurrence of beta-lactamase type ESBL in rods of the Serratia species].
    Ulatowska B; Czajkowski H; Gospodarek E; Mikucka A
    Med Dosw Mikrobiol; 2000; 52(1):17-24. PubMed ID: 11107776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rare pathogen for subacute osteomyelitis in adolescent: Serratia marcescens.
    Turgut N; Akgul T; Arzu U; Batıbay SG; Ekinci M; Şen C; Korkmaz M
    Int J Surg Case Rep; 2015; 8C():171-4. PubMed ID: 25704404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients.
    Tanır Basaranoglu S; Ozsurekci Y; Aykac K; Karadag Oncel E; Bıcakcigil A; Sancak B; Cengiz AB; Kara A; Ceyhan M
    Ital J Pediatr; 2017 Sep; 43(1):79. PubMed ID: 28899399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing
    Wang Y; Xiao T; Zhu Y; Ye J; Yang K; Luo Q; Shen P; Xiao Y
    Infect Drug Resist; 2020; 13():3583-3592. PubMed ID: 33116678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit.
    Morkel G; Bekker A; Marais BJ; Kirsten G; van Wyk J; Dramowski A
    Paediatr Int Child Health; 2014 May; 34(2):108-14. PubMed ID: 24621234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
    Sfeir MM; Askin G; Christos P
    Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.
    Rhee C; Kadri SS; Dekker JP; Danner RL; Chen HC; Fram D; Zhang F; Wang R; Klompas M;
    JAMA Netw Open; 2020 Apr; 3(4):e202899. PubMed ID: 32297949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.